Open AccessClinical experience of switching from biphasic human insulin to biphasic insulin aspart 30 in Indian patients with type 2 diabetes in the A 1 chieve study
Author(s) -
Das Ak,
Sanjay Kalra,
Shabbir Akhtar,
Raviraj Shetty,
Ajay Kumar
Publication year - 2015
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/2230-8210.131759
Subject(s) - medicine , postprandial , hypoglycemia , glycated hemoglobin , insulin aspart , diabetes mellitus , type 2 diabetes , insulin , adverse effect , endocrinology
The aim of the following study is to evaluate the safety and effectiveness of switching from biphasic human insulin (BHI) to biphasic insulin aspart 30 (BIAsp 30) in Indian patients with type 2 diabetes as a sub-analysis of the 24-week, non-interventional A1chieve study.